Log in
Enquire now
‌

US Patent 9701753 Hyperglycosylated binding polypeptides

Patent 9701753 was granted and assigned to Genzyme on July, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent

Patent attributes

Patent Applicant
Genzyme
Genzyme
Current Assignee
Genzyme
Genzyme
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9701753
Patent Inventor Names
Diego Gianolio2
Pradeep Dhal2
Bo Chen2
Clark Pan2
Huawei Qiu2
Date of Patent
July 11, 2017
Patent Application Number
14203438
Date Filed
March 10, 2014
Patent Citations Received
‌
US Patent 12110338 Site-specific antibody-drug conjugation through glycoengineering
1
Patent Primary Examiner
‌
Phuong Huynh
Patent abstract

Provided are binding polypeptides (e.g., antibodies), and effector moiety conjugates thereof, comprising a CH1 domain (e.g., a human IgG1 CH1 domain), wherein the CH1 domain has an engineered N-linked glycosylation site at amino acid position 114, according to Kabat numbering. Also provided are nucleic acids encoding the antigen-binding polypeptides, recombinant expression vectors and host cells for making such antigen-binding polypeptides. Methods of using the antigen-binding polypeptides disclosed herein to treat disease are also provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9701753 Hyperglycosylated binding polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us